Skip to main content
VSEE logo

VSEE · Vsee Health, Inc. · Documents

Track VSEE — free
$0.03 -0.02 (-34.00%) At close · Aug 6
Market Cap
$1.59M
Shares
708,498
Volume · Aug 6 5.75M Avg daily vol (3M) —

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $14.62M up 40.3% 10-K filed Mar 31, 2026 Quarterly report FY2026 Q2 Revenue $1.56M up 48.0% 10-Q filed Aug 14, 2026 Latest results Financial results 8-K filed Nov 18, 2024
2026
Oct 1
Registration statement S-1
Registration statement

VSee Health, Inc. registered up to 3,540,000 common shares for resale by ClearThink Capital Partners, LLC, comprising 40,000 commitment-fee shares and 3,500,000 shares issuable under a $5.0 million purchase commitment dated September 2, 2026.

Read from the first part of this long document
Sep 23
Current report 8-K Events of Sep 22
Charter or bylaw amendment, or fiscal year change

VSee Health, Inc. effected a 1-for-80 reverse stock split of its Common Stock at 5:00 p.m., eastern time on September 23, 2026; split-adjusted trading begins at the market open on Thursday, September 24, 2026.

Jul 20
Proxy statement DEF 14A Meeting Aug 25, 2026
Proxy statement AI summary on its way
Jul 10
Proxy statement PRE 14A Meeting Aug 25, 2026
Proxy statement AI summary on its way
May 15
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $3.16M ▼ 4.9% Net loss $2.6M Diluted EPS -$0.05
Mar 31
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $14.62M ▲ 40.3% Net loss $14.71M Diluted EPS -$0.73
Feb 5
Proxy statement DEF 14A Meeting Mar 2, 2026
Proxy statement AI summary on its way
Jan 26
Proxy statement PRE 14A Meeting Mar 2, 2026
Proxy statement AI summary on its way
2025
Showing 1–50 of 154 documents
Key facts CIK 1864531 CUSIP 92919Y102 Visit website Investor relations